December 3, 2014
Abraham Morgentaler, MD, FACS
Hypogonadal men treated with testosterone therapy are not at increased risk for prostate cancer, according to research published in The Journal of Urology.
Ahmad Haider, MD, PhD, a urologist in Bremerhaven, Germany, and colleagues said testosterone treatment is safe in hypogonadal men if therapy guidelines are properly applied.
In the Journals
December 1, 2014
Olaparib monotherapy induced responses across tumor types in patients with germline BRCA1 or BRCA2 mutations, according to results of a multicenter phase 2 study.The…
In the JournalsPerspective
November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related neuroendocrine…
Meeting News Coverage
November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had…